The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry – including DeepCognito Ltd.
Today (Tuesday 6 November), Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD as part of the Industrial Strategy Challenge Fund.
Transcript excerpt (The Right Honourable Greg Clark):
“AI has the potential to revolutionise healthcare and improve lives for the better. That’s why our modern Industrial Strategy puts pioneering technologies at the heart of our plans to build a Britain fit for the future.”
“The innovation at these new centres will help diagnose disease earlier to give people more options when it comes to their treatment, and make reporting more efficient, freeing up time for our much-admired NHS staff time to spend on direct patient care.”
Partner companies in the University of Glasgow-led pan Scotland consortium, Canon Medical Research Europe Ltd and Philips, along with six SMEs, will provide more than £5M of additional funding to support iCAIRD.
iCAIRD will be a Scottish centre of excellence and focus on the application of AI in digital diagnostics, ultimately enabling better and earlier diagnosis and more efficient treatment for patients. It is also predicted that iCAIRD will create new jobs centred around AI and digital technology in healthcare.
Founding iCAIRD partners are (in alphabetical order): Bering Ltd, Canon Medical Research Europe Ltd, Cytosystems Ltd, DeepCognito Ltd, Glencoe Software, HDRUK Scotland and Scotland’s National and Regional Safe Havens, Intersystems, Kheiron Medical Technology, NHS Grampian, NHS Greater Glasgow & Clyde, NHS National Services Scotland, NVidia, Philips, University of Aberdeen, University of Edinburgh, University of Glasgow (hub site of iCAIRD) and University of St Andrews.